邢 雷, 孔令泉, 厉红元, 任国胜, 罗 凤, 吴凯南. 乳腺癌患者携带PICC化疗并发PICC相关性上肢深静脉血栓形成的诊治探讨[J]. 中国肿瘤临床, 2011, 38(19): 1223-1226. DOI: 10.3969/j.issn.1000-8179.2011.19.012
引用本文: 邢 雷, 孔令泉, 厉红元, 任国胜, 罗 凤, 吴凯南. 乳腺癌患者携带PICC化疗并发PICC相关性上肢深静脉血栓形成的诊治探讨[J]. 中国肿瘤临床, 2011, 38(19): 1223-1226. DOI: 10.3969/j.issn.1000-8179.2011.19.012
Lei XING, Lingquan KONG, Hongyuan LI, Guosheng REN, Feng LUO, Kainan WU. Diagnosis and Treatment of PICC-related Upper Extremity Deep Vein Thrombosis in Breast Cancer Patients[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(19): 1223-1226. DOI: 10.3969/j.issn.1000-8179.2011.19.012
Citation: Lei XING, Lingquan KONG, Hongyuan LI, Guosheng REN, Feng LUO, Kainan WU. Diagnosis and Treatment of PICC-related Upper Extremity Deep Vein Thrombosis in Breast Cancer Patients[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(19): 1223-1226. DOI: 10.3969/j.issn.1000-8179.2011.19.012

乳腺癌患者携带PICC化疗并发PICC相关性上肢深静脉血栓形成的诊治探讨

Diagnosis and Treatment of PICC-related Upper Extremity Deep Vein Thrombosis in Breast Cancer Patients

  • 摘要: 探讨乳腺癌患者携带PICC化疗出现PICC相关性上肢深静脉血栓形成的发生及其临床诊治。方法:回顾性分析本院2009年8月~2011年7月携带PICC化疗的187例乳腺癌患者中PICC相关性上肢深静脉血栓形成的发生及其临床诊治情况。结果:187例携带PICC化疗的乳腺癌患者,共放置PICC188根,PICC管总置管时间为14,399天,平均置管时间为76.6天,最长170天。4例在PICC置管后14~112d(平均45.25d)出现上肢深静脉血栓形成,发生率为2.1%,发病密度为0.28/PICC置管1 000天(0.28‰)。结论:乳腺癌患者化疗期间携带PICC化疗是一种安全有效的方法,但少数病例可能出现PICC相关性上肢深静脉血栓形成,此时应注意观察患者的症状和体征,早期发现,正确诊治,患者均能获得较好的疗效。

     

    Abstract: The current research aims to study the incidence, diagnosis, and treatment of deep vein thrombosis ( DVT ) in breast cancer patients with peripherally inserted central catheters ( PICCs ) during chemotherapy. Methods: Data of the incidence, diagnosis, and treatment for the PICC-related DVT in 187 breast cancer patients who underwent chemotherapy from August 2009 to July 2011 were retrospectively analyzed. Results: A total of 188 PICCs were inserted in the patients from August 2009 until July 2011 and were followed up for a total of 14,399 catheter-days ( median, 76.6 d; range, 1-170 d ). Four ( 2.1% ) of the 188 PICCs were removed as a result of PICC-related DVT in 14 to 112 catheter-days after the catheter placement, with an incidence of 0.28 per 1,000 catheter-days. Conclusion: Application of PICC in breast cancer patients during chemotherapy is a safe and effective method. However, some patients may develop catheter-related DVT. To achieve a markedly satisfactory therapeutic effect, careful attention should be paid on the signs and symptoms of the patients.

     

/

返回文章
返回